Cypress Bioscience, Inc. - Investor Relations

Corporate Governance
Investor FAQs
Investor Relations
     Stock Information
     News
     Fundamentals
     Analyst Coverage
     Earnings Estimates
     Dividends and Splits
     SEC Filings
     Request Information

Investor Relations

Corporate profile

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services to facilitate improved and individualized patient care. Cypress’ goal is to address the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. more

Stock Quote

CYPB (common stock)
Exchange	NASDAQ (US Dollar)
Price	$4.83
Change (%)	0.07 (1.43%)
Volume	394,896
Data as of 03/11/10 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Upcoming Events

There are currently no events scheduled.

Featured Report

There are currently no items available.

Recent News

Date	Title
03/08/10	Cypress Bioscience, Inc. to Present at Cowen and Company 30th Annual Health Care Conference
02/26/10	Cypress Bioscience, Inc. to Participate in RBC Capital Markets Healthcare Conference
02/05/10	Cypress Bioscience, Inc. to Participate in BIO CEO & Investor Conference
11/30/09	Cypress Bioscience, Inc. to Present at the Piper Jaffray 21st Annual Health Care Conference

Contact Information

Primary IR Contact

Investor Relations
Cypress Bioscience, Inc.
4350 Executive Drive
Suite 325
San Diego, CA 92121
Phone: (858) 452-2323
Fax: (858) 452-1222
E-mail: ir-info@cypressbio.com

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Privacy Legal Disclaimer